The elevated soluble PDGFRB in cerebrospinal fluid correlates with the severity of blood-brain barrier breakdown and pericyte injury, an important pathologic process in AD (Sagare et al., 2015). The gene discussed is PDGFRB; the disease is Alzheimer disease.